These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 17937588)

  • 1. Nanotechnology and cancer.
    Heath JR; Davis ME
    Annu Rev Med; 2008; 59():251-65. PubMed ID: 17937588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology for sensing, imaging, and treating cancer.
    Panchapakesan B; Wickstrom E
    Surg Oncol Clin N Am; 2007 Apr; 16(2):293-305. PubMed ID: 17560513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging implications of nanotechnology on cancer diagnostics and therapeutics.
    Cuenca AG; Jiang H; Hochwald SN; Delano M; Cance WG; Grobmyer SR
    Cancer; 2006 Aug; 107(3):459-66. PubMed ID: 16795065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanotherapeutic approaches to target mitochondria in cancer.
    Mani S; Swargiary G; Tyagi S; Singh M; Jha NK; Singh KK
    Life Sci; 2021 Sep; 281():119773. PubMed ID: 34192595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging nanotechnology based strategies for diagnosis and therapeutics of urinary tract infections: A review.
    Kumar MS; Das AP
    Adv Colloid Interface Sci; 2017 Nov; 249():53-65. PubMed ID: 28668171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Nanotechnology-based Drug Delivery Systems in Cancer Treatment.
    Ho BN; Pfeffer CM; Singh ATK
    Anticancer Res; 2017 Nov; 37(11):5975-5981. PubMed ID: 29061776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.
    Ptak K; Farrell D; Panaro NJ; Grodzinski P; Barker AD
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(5):450-60. PubMed ID: 20552623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Based Drug Delivery Systems for Enhanced Tumor-Targeting Treatment.
    Li Y; Zhang H
    J Biomed Nanotechnol; 2019 Jan; 15(1):1-27. PubMed ID: 30480512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is cancer nanotechnology?
    Grobmyer SR; Iwakuma N; Sharma P; Moudgil BM
    Methods Mol Biol; 2010; 624():1-9. PubMed ID: 20217585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique benefits of nanotechnology to drug delivery and diagnostics.
    McNeil SE
    Methods Mol Biol; 2011; 697():3-8. PubMed ID: 21116949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of nanotechnology in cancers prevention, early detection and treatment.
    Patel SP; Patel PB; Parekh BB
    J Cancer Res Ther; 2014; 10(3):479-86. PubMed ID: 25313725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional nanoplatforms for enhancement of chemotherapeutic index.
    Yang J; Lee E; Ku M; Huh YM; Cheong JH
    Anticancer Agents Med Chem; 2013 Feb; 13(2):212-21. PubMed ID: 22934694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Cancer Institute Alliance for nanotechnology in cancer-Catalyzing research and translation toward novel cancer diagnostics and therapeutics.
    Hartshorn CM; Russell LM; Grodzinski P
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Nov; 11(6):e1570. PubMed ID: 31257722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nanotechnology in the war against cancer: new arms against an old enemy - a clinical view.
    Friberg S; Nyström AM
    Future Oncol; 2015; 11(13):1961-75. PubMed ID: 26161930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cancer precision theranostics: a focus on multifunctional gold nanoparticles.
    Cabral RM; Baptista PV
    Expert Rev Mol Diagn; 2014 Nov; 14(8):1041-52. PubMed ID: 25314939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe Nanoparticles: Are We There Yet?
    Najahi-Missaoui W; Arnold RD; Cummings BS
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33396561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colloidal gold: a novel nanoparticle for targeted cancer therapeutics.
    Powell AC; Paciotti GF; Libutti SK
    Methods Mol Biol; 2010; 624():375-84. PubMed ID: 20217609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotechnology meets 3D in vitro models: tissue engineered tumors and cancer therapies.
    da Rocha EL; Porto LM; Rambo CR
    Mater Sci Eng C Mater Biol Appl; 2014 Jan; 34():270-9. PubMed ID: 24268259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care.
    Hartshorn CM; Bradbury MS; Lanza GM; Nel AE; Rao J; Wang AZ; Wiesner UB; Yang L; Grodzinski P
    ACS Nano; 2018 Jan; 12(1):24-43. PubMed ID: 29257865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology-based drug delivery for cancer.
    Jain KK
    Technol Cancer Res Treat; 2005 Aug; 4(4):407-16. PubMed ID: 16029059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.